HealthStream Inc has a consensus price target of $31 based on the ratings of 3 analysts. The high is $34 issued by Barclays on October 23, 2024. The low is $28 issued by Canaccord Genuity on December 17, 2025. The 3 most-recent analyst ratings were released by Canaccord Genuity on December 17, 2025, August 7, 2025, and May 15, 2025, respectively. With an average price target of $28.33 between Canaccord Genuity, there's an implied 38.55% upside for HealthStream Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for HealthStream (NASDAQ:HSTM) was reported by Canaccord Genuity on December 17, 2025. The analyst firm set a price target for $28.00 expecting HSTM to rise to within 12 months (a possible 36.92% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for HealthStream (NASDAQ:HSTM) was provided by Canaccord Genuity, and HealthStream maintained their hold rating.
There is no last upgrade for HealthStream
There is no last downgrade for HealthStream.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HealthStream, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HealthStream was filed on December 17, 2025 so you should expect the next rating to be made available sometime around December 17, 2026.
While ratings are subjective and will change, the latest HealthStream (HSTM) rating was a maintained with a price target of $28.00 to $28.00. The current price HealthStream (HSTM) is trading at is $20.45, which is out of the analyst’s predicted range.